Article
An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders
5 Mar 2018
Abstract excerpt
BACKGROUND: The use of oral progestin has been shown to effectively prevent luteining hormone (LH) surge during ovarian stimulation with daily human menopausal gonadotropin injections. This study was aimed to investigate the efficacy of long-acting follicle stimulating hormone (long-acting FSH; corifollitropin alfa, Elonva®) use in progestin-primed ovarian stimulation for normal and high responders undergoing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
